Literature DB >> 10519422

Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.

M T Rizzo1, E Regazzi, D Garau, L Akard, M Dugan, H S Boswell, V Rizzoli, C Carlo-Stella.   

Abstract

The hallmark of chronic myeloid leukemia (CML) is the presence of the bcr-abl oncogene, which is associated with transforming ability and an intrinsic resistance to induction of apoptosis by genotoxic agents. Arachidonic acid (AA), a biologically active fatty acid, plays a crucial role as a mediator of signaling pathways involved in cell proliferation and survival. In this study, we investigated the potential role of AA as a proapoptotic agent in CML. Pretreatment of human CML isolated progenitor cells with AA (100 microM for 18 h) induced 71-75% inhibition of in vitro colony formation of granulocyte-macrophage colony-forming units, multilineage colony-forming units, and erythroid burst-forming units. This inhibition was significantly greater than the effect on normal progenitor cells (19-39% growth inhibition of erythroid burst-forming units, multilineage colony-forming units, and granulocyte-macrophage colony-forming units). AA also inhibited growth of the bcr-abl-transformed cell line H7.bcr-abl A54. In contrast, a minimal effect of AA on inhibition of cell growth was observed in the parental nontransformed NSF/N1.H7 cell line. The antiproliferative effect of AA was associated with apoptosis. Gamma-linolenic acid, a precursor of AA, also inhibited cell growth, whereas other unsaturated and saturated fatty acids had no effect. Pharmacological inhibition of cyclooxygenase, lipooxygenase, and cytochrome P450 monooxygenase enzymes prior to exposure to AA did not rescue cells from the inhibitory effect of AA. Moreover, 5,8,11,14-eicosatetraynoic acid, a nonmetabolizable arachidonate analogue, also inhibited cell growth, suggesting that the effect of AA did not require further metabolism. Treatment with antioxidants prior to stimulation with AA was also ineffective in preventing its antiproliferative effect. Thus, AA inhibited proliferation of CML cells by inducing apoptotic cell death. The signaling mechanisms of AA-induced inhibition of cell growth appeared to be independent of its conversion into eicosanoids or free radical generation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519422

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  A rare eicosanoid precursor analogue, sciadonic acid (5Z,11Z,14Z-20:3), detected in vivo in hormone positive breast cancer tissue.

Authors:  H G Park; J Y Zhang; C Foster; D Sudilovsky; D A Schwed; J Mecenas; S Devapatla; P Lawrence; K S D Kothapalli; J T Brenna
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-05-16       Impact factor: 4.006

Review 2.  Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism.

Authors:  J Davidson; D Rotondo; M T Rizzo; H A Leaver
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.

Authors:  Song Xu; Rongjuan Pei; Min Guo; Qingxia Han; Juan Lai; Yun Wang; Chunchen Wu; Yuan Zhou; Mengji Lu; Xinwen Chen
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 4.  Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.

Authors:  Suree Lekawanvijit; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

5.  Antineoplastic unsaturated fatty acids from Fijian macroalgae.

Authors:  Ren-Wang Jiang; Mark E Hay; Craig R Fairchild; Jacques Prudhomme; Karine Le Roch; William Aalbersberg; Julia Kubanek
Journal:  Phytochemistry       Date:  2008-08-29       Impact factor: 4.072

6.  Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.

Authors:  Kshama Natarajan; Noriko Mori; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

7.  Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro.

Authors:  Undurti N Das; N Madhavi
Journal:  Lipids Health Dis       Date:  2011-09-14       Impact factor: 3.876

8.  Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro.

Authors:  Sailaja Polavarapu; Arul M Mani; Naveen K V Gundala; Anasuya D Hari; Siresha Bathina; Undurti N Das
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

9.  Profiling of the perturbed metabolomic state of mouse spleen during acute and chronic toxoplasmosis.

Authors:  Xiao-Qing Chen; Chun-Xue Zhou; Hany M Elsheikha; Shuai He; Gui-Xue Hu; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2017-07-18       Impact factor: 3.876

10.  Differential action of polyunsaturated fatty acids and eicosanoids on bleomycin-induced cytotoxicity to neuroblastoma cells and lymphocytes.

Authors:  Sailaja Polavarapu; Bilikere S Dwarakanath; Undurti N Das
Journal:  Arch Med Sci       Date:  2017-12-19       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.